Graham G. Walmsley's Form 4/A amendment
AmendedOlema Pharmaceuticals, Inc. (OLMA) · filed May 13, 2025
- Accession no.
- 0000935836-25-000323
- Filed
- May 13, 2025
- Rule 10b5-1 plan
- Not checked
- Original filed
- Dec 17, 2024
This filing lists no transactions. It carries over 2 transactions from the original filing that it did not restate. Open-market purchases total $4.73M. Open-market sales total $4.73M.
This amendment restates part of 0000935836-24-000764 (filed Dec 18, 2024). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Graham G. WalmsleyCIK 0001777517 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0000935836-24-000764 (filed Dec 18, 2024).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2024 | Common Stock | SSaleDisposed | −700,761 | $6.75 | −$4,730,136.75 | 0 | Indirect | |
| Dec 13, 2024 | Common Stock | PPurchaseAcquired | +700,761 | $6.75 | +$4,730,136.75 | 700,761 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
These securities are held by Logos Global Master Fund LP ("Logos Master Fund"). This holding was inadvertently omitted from the Form 4 filed by the reporting person on December 17, 2024. Logos Master Fund did not participate in the transactions reported in that Form 4. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.